Company intelligence / Profile preview

GeoPharma

Largo, Florida, United Statesgeopharma.co ↗

Ownership: Private
Development stage: Commercial

Overview

GeoPharma, Inc. developed a diversified portfolio including generic pharmaceuticals for human and veterinary use, nutraceuticals, cosmeceuticals, medical devices, and an early-stage ovarian cancer diagnostic. The US-based business closed in 2015. An unrelated Italian Geopharma focused on osteoarticular nutraceuticals was acquired by DOC Pharma in early 2025.

Therapeutic areas: OtherRheumatologyOncologyNeurology
Modalities: Small moleculeNutraceuticals
Industry: Biotech

Partnerships

Trident Biotech

Beyond the preview

Go deeper on GeoPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeoPharma.

Explore the full profile